Congress Materials

Medical Information
India
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for India Healthcare Professionals. Would you like to proceed?

I am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
I am a patient/caregiver residing in IndiaNo, go back to the patient portal
SelectI am a patient/caregiver residing in IndiaNo, go back to the patient portal
Non-India residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Jacob P. Thyssen, Anthony Bewley, Sonja Ständer, Carla Castro, Laurent Misery, Brian Kim, Pinaki Biswas, Gary Chan, Daniela E. Myers, Melissa Watkins, Justine Alderfer, Erman Guler, Jonathan I. Silverberg April 11, 2022 RAD - April 2022 Dermatology

Abrocitinib Reduces Skin Pain in Adolescent and Adult Patients With Moderate-to-Severe Atopic Dermatitis

View Presentation
Poster
Andrew Blauvelt, Peter A. Lio, Melinda J. Gooderham, James Q. Del Rosso, Leon Kircik, Ama Alexis, Jacob P. Thyssen, Gary Chan, Pinaki Biswas, Urs Kerkmann, Daniela E. Myers, Mark Levenberg April 11, 2022 RAD - April 2022 Dermatology

Effect of Abrocitinib on Individual Signs of Atopic Dermatitis Assessed by Eczema Area and Severity Index (EASI) Subscores

View Presentation
Poster
April W. Armstrong, Andrew Blauvelt, Melinda J. Gooderham, H. Chih-ho Hong, Fan Zhang, Claire Feeney, Claire Clibborn, Daniela E. Myers, Gary Chan April 11, 2022 RAD - April 2022 Dermatology

High-Level Responses Across Multiple Domains in Patients With Atopic Dermatitis Treated with Abrocitinib versus Dupilumab: A Post Hoc Analysis of a Phase 3 Randomized Trial

View Presentation
Poster
Linda Stein Gold, Vivian Y. Shi, Bonnie Vlahos, Paul Sanders, Chuanbo Zang, Amy Cha April 11, 2022 RAD - April 2022 Dermatology

Impact of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis Who Received Prior Treatment

View Presentation
Poster
Eric Simpson, Raj Chovatiya, Peter Schmid-Grendelmeier, Irina Lazariciu, Daniela E. Myers, Claire Clibborn April 11, 2022 RAD - April 2022 Dermatology

Multidomain Responses to Abrocitinib 100 mg With or Without Background Topical Medications in Adults With Atopic Dermatitis: A Post Hoc Analysis

View Presentation